Article
Modification of the Fc Region of a Human Anti-oncostatin M Monoclonal Antibody for Higher Affinity to FcRn Receptor and Extension of Half-life in Cynomolgus Monkeys.
Basic & clinical pharmacology & toxicology - 1 Jul 2017
Nnane Ivo P, Han Chao, Jiao Qun, Tam Susan H, Davis Hugh M, Xu Zhenhua
Abstract excerpt
The purpose of this study was to evaluate the pharmacokinetics (PK) of anti-oncostatin M (OSM) IgG1 monoclonal antibodies, CNTO 1119 and its Fc variant (CNTO 8212), which incorporates the LS(Xtend) mutation to extend terminal half-life (T1/2 ), after a single intravenous (IV) or subcutaneous (SC) administration in cynomolgus monkeys, and to predict human PK. In study 1, single doses of CNTO 1119 and CNTO 8212...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.